Annual Report

Overview

The report presents Sandu Pharmaceuticals' 40th Annual Report for FY 2024-25, with consolidated revenue from operations of 6719.24 and profit for the period of 155.17, in INR Lakhs. It highlights Ayurvedic product development and sustainability actions involving eco-friendly packaging, sustainable sourcing, and energy-efficient operations. The report also discloses 303 permanent employees on roll.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2024-2025
Period: 1 April 2024 – 31 March 2025
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services